This is a type of test that uses radioactive materials and antibodies to measure proteins in your blood. It's a specific way to check for certain proteins.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
The radioimmunosorbent test (RIST) is a laboratory method for measuring the total amount of immunoglobulin E (IgE) in a blood sample. IgE is the antibody behind allergic reactions such as hay fever, allergic asthma and food allergy, and it also takes part in the immune response to parasitic infections. RIST was one of the first ways to measure it and relied on radioactive labels. It has largely been replaced by non-radioactive immunoassays that measure the same thing, so today the order is usually simply called a total IgE test. Total IgE is different from a specific IgE test (once called RAST), which checks for IgE against one particular allergen such as peanut or dust mite. A total IgE result can suggest that the allergic side of the immune system is active, but on its own it has limited value for diagnosing allergy. It is most useful in a few defined situations. Before starting omalizumab (Xolair), an injected antibody medicine for allergic asthma, nasal polyps and IgE-mediated food allergy, the measured IgE level and body weight set the dose. A markedly raised level (500 international units per milliliter, written IU/mL, or more under current international criteria) is also part of diagnosing allergic bronchopulmonary aspergillosis, an allergic reaction to mold in the airways of people with asthma or cystic fibrosis.
A total IgE test usually needs no special preparation, and fasting is not normally required. If the test is part of a wider set of blood work, the care team will say whether any of the other tests need fasting. Tell the person ordering the test if you have ever received omalizumab, because it raises measured total IgE for up to a year after the last dose and changes how the result is read.
The test is an ordinary blood draw. A health professional cleans the skin, places a small needle into a vein, usually in the arm, and fills a tube. It typically takes less than five minutes, and most people feel only a brief sting. The sample then goes to a laboratory, where the IgE in the blood is captured by antibodies fixed to a solid surface and measured. In the original RIST that measurement used a radioactive tracer; current methods use enzyme or fluorescent signals instead. None of this involves radiation exposure for the person tested.
Normal activities can resume right away. A small bruise or soreness where the needle went in is common and fades within a few days. Results usually come back within days and are reported in IU/mL or the equivalent kU/L (kilounits per liter). What counts as normal varies between laboratories, populations and ages, so the result is compared with the reporting lab's reference range. A high total IgE does not show what someone is allergic to or how serious an allergy is, and a normal result does not rule allergy out. Clinicians interpret it alongside symptoms, history and, when needed, skin tests or allergen-specific IgE tests. If the test was ordered for omalizumab, the number is used to choose the starting dose; repeat tests during treatment are not used to adjust it.
The physical risks are those of any blood draw: brief discomfort, bruising and, uncommonly, lightheadedness or fainting. People who tend to faint with needles can ask to lie down. The more realistic drawback is overreading the result. Total IgE can be raised by many things besides allergy, and the cutoff for normal is not standardized, so a single high number can cause worry or lead to further testing that does not change care. The test answers a narrow question, and its value depends on why it was ordered.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Radioimmunosorbent Test, what to expect, or ask the community a question.